Pressurized aerosol inhalers, which are designed for administering drugs to treat asthma and other lung disorders, have undergone a transition where chlorofluorocarbons (CFCs) formerly used as propellants have been replaced by alternative substances. This modification was prompted by compelling evidence indicating that CFCs have detrimental effects on the ozone layer within the Earth’s atmosphere.